01Production facilityAntigen produced in a facility approved for Biosafety level 2
Established and standardized mass production process for viruses, bacteria, and recombinant proteins
Optimized mass production methods for each antigen
Produced raw materials and established a systematic quality management system
02Antigen productionWe have the technology of manufacturing antigen to produce products with high antibody titers differentiated from other companies
We have the technology for manufacturing complex antigens for virus and bacteria complex antigens and recombinant proteins
We have the technology to concentrate and refine highly concentrated antigen and antibodies and a patent registered for thermal stability.
03Antigen libraryThere are about 300 species including viruses, bacteria, and recombinant antigens that cause digestive diseases
Continuous analysis and application of new disease pathogens
Producing recombinant protein for disease-causing agents that cannot be applied, such as parasites, cholesterol, and fertilized egg culture
04Vaccination programResearch on the combination of complex antigen that can produce optimal antibody titers against existing and new antigens
Optimized the program through preliminary tests for the vaccination intervals for complex antigen/vaccine amount, the number of vaccination, etc.
When a new antigen is developed, we search for an optimized ratio through a preliminary test, and carry out mass vaccination of the farm